Snap-8 is a peptide that comes up in research and cosmetic-ingredient discussions, and people searching for it often want to know whether it has any formal clinical backing. It does not currently carry an FDA-approved label, so no approved medical use can be described here.
Key takeaways
- Snap-8 has no FDA-approved label and no approved medical indication.
- It is classified under unapproved research status.
- No registered clinical trials for Snap-8 were found in the data reviewed.
- Its chemical identity is catalogued in PubChem (CID 71587832).
What Snap-8 is
Snap-8 is an oligopeptide with a molecular formula of C42H72N16O15S and a molecular weight of about 1,073 g/mol. Beyond this chemical identity, there is no FDA label describing an approved drug class or mechanism of action for it. It should be understood as a research-stage compound rather than an approved pharmaceutical product.
What the evidence shows
The data reviewed show zero registered clinical trials for Snap-8. No trial titles, phases, or statuses are available to summarize because none appear in the records checked.